GDF15 and hydrops fetalis: Despite the finding that a 20% increase in GDF-15 levels was associated with a statistically significant higher risk of mortality and poor CV outcomes in the PARADIGM-HF study population, GDF-15 levels were not affected by sacubitril–valsartan therapy [63].